Cargando…
Formulation and development of paediatric orally disintegrating carbamazepine tablets
Carbamazepine is a medicine used to manage epilepsy and partial or tonic-clonic seizures. This study aimed at formulating and obtaining carbamazepine orodispersible tablets for paediatric use at a 50 mg dose, with a diameter not greater than 6 mm and a tablet weight of 80 mg, through a direct compre...
Autores principales: | Canadell-Heredia, R, Suñé-Pou, M, Nardi-Ricart, A, Pérez-Lozano, P, Suñé-Negre, JM, García-Montoya, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715948/ https://www.ncbi.nlm.nih.gov/pubmed/36465846 http://dx.doi.org/10.1016/j.jsps.2022.09.004 |
Ejemplares similares
-
Development of a Carvedilol Oral Liquid Formulation for Paediatric Use
por: Chiclana-Rodríguez, Blanca, et al.
Publicado: (2023) -
Robustness Optimization of an Existing Tablet Coating Process Applying Retrospective Knowledge (rQbD) and Validation
por: Galí, Albert, et al.
Publicado: (2020) -
Formulation of Sustained Release Hydrophilic Matrix Tablets of Tolcapone with the Application of Sedem Diagram: Influence of Tolcapone’s Particle Size on Sustained Release
por: Nardi-Ricart, Anna, et al.
Publicado: (2020) -
Excipients in the Paediatric Population: A Review
por: Rouaz, Khadija, et al.
Publicado: (2021) -
Methods for Developing a Process Design Space Using Retrospective Data
por: Romero-Obon, Miquel, et al.
Publicado: (2023)